🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/12/2008 | 28,50 | 30,27 | 28,41 | 30,10 | +6,17% | 6,53% | 1.566.200 |
| 15/12/2008 | 29,45 | 29,65 | 27,92 | 28,35 | -3,04% | 5,87% | 1.023.200 |
| 12/12/2008 | 27,09 | 29,25 | 26,41 | 29,24 | +6,33% | 10,47% | 1.457.800 |
| 11/12/2008 | 28,16 | 28,64 | 27,01 | 27,50 | -3,05% | 5,77% | 1.827.200 |
| 10/12/2008 | 28,35 | 29,33 | 28,14 | 28,37 | +1,00% | 4,18% | 853.800 |
| 09/12/2008 | 27,84 | 29,20 | 27,64 | 28,09 | +0,07% | 5,62% | 1.565.200 |
| 08/12/2008 | 27,28 | 28,50 | 27,06 | 28,07 | +4,47% | 5,30% | 1.814.800 |
| 05/12/2008 | 25,34 | 26,96 | 24,80 | 26,87 | +4,66% | 8,53% | 1.158.600 |
| 04/12/2008 | 26,21 | 26,57 | 25,27 | 25,67 | -2,21% | 4,96% | 1.876.200 |
| 03/12/2008 | 25,56 | 26,65 | 25,37 | 26,25 | +0,94% | 5,01% | 2.058.600 |
| 02/12/2008 | 26,04 | 26,34 | 24,60 | 26,01 | +1,48% | 6,66% | 2.475.600 |
| 01/12/2008 | 26,87 | 26,98 | 25,54 | 25,63 | -6,53% | 5,36% | 1.443.000 |
| 28/11/2008 | 27,40 | 27,64 | 26,67 | 27,42 | -1,37% | 3,52% | 337.400 |
| 26/11/2008 | 26,49 | 28,20 | 25,57 | 27,80 | +2,70% | 9,95% | 1.409.400 |
| 25/11/2008 | 25,35 | 27,18 | 24,67 | 27,07 | +6,91% | 9,90% | 2.227.600 |
| 24/11/2008 | 25,06 | 25,73 | 24,31 | 25,32 | +1,50% | 5,65% | 2.289.400 |
| 21/11/2008 | 24,88 | 24,99 | 23,82 | 24,94 | +1,78% | 4,70% | 2.312.000 |
| 20/11/2008 | 25,56 | 26,14 | 24,32 | 24,51 | -4,96% | 7,12% | 4.024.600 |
| 19/11/2008 | 27,75 | 28,23 | 25,69 | 25,79 | -6,91% | 9,15% | 2.966.600 |
| 18/11/2008 | 29,41 | 29,53 | 26,95 | 27,70 | -5,49% | 8,77% | 5.169.800 |
| 17/11/2008 | 30,26 | 31,09 | 28,15 | 29,31 | -35,24% | 9,72% | 17.493.600 |
| 14/11/2008 | 46,62 | 46,65 | 44,34 | 45,26 | -3,59% | 4,95% | 1.404.600 |
| 13/11/2008 | 44,35 | 46,98 | 42,78 | 46,95 | +5,67% | 9,48% | 1.564.000 |
| 12/11/2008 | 43,85 | 45,96 | 43,49 | 44,43 | -1,17% | 5,63% | 1.843.800 |
| 11/11/2008 | 42,86 | 45,68 | 42,21 | 44,95 | +4,06% | 8,09% | 2.097.000 |
| 10/11/2008 | 44,52 | 44,52 | 42,60 | 43,20 | -2,11% | 4,32% | 1.059.200 |
| 07/11/2008 | 42,97 | 44,37 | 42,33 | 44,13 | +3,07% | 4,74% | 797.200 |
| 06/11/2008 | 43,11 | 43,96 | 41,93 | 42,81 | -1,70% | 4,70% | 1.031.400 |
| 05/11/2008 | 43,30 | 44,17 | 42,88 | 43,55 | +0,23% | 2,98% | 930.200 |
| 04/11/2008 | 45,25 | 45,25 | 41,62 | 43,45 | -3,47% | 8,02% | 1.912.000 |